On September 22, 2025, President Donald Trump stood before cameras and announced that his administration had identified a cause of autism: acetaminophen — sold as Tylenol in the United States and known as paracetamol in most of the world — taken by pregnant women. Health and Human Services Secretary Robert F. Kennedy Jr., who had promised in April to pinpoint the cause of autism by September, declared that the culprit had been found. He also promoted leucovorin (calcium folinate) as a treatment for autistic individuals.
The response from the medical community was immediate and overwhelming: the evidence does not support this claim.
Within days, the American College of Obstetricians and Gynecologists (ACOG) affirmed the safety and benefits of acetaminophen during pregnancy. The Society for Maternal-Fetal Medicine (SMFM) issued a formal rebuttal. The UK's Medicines and Healthcare products Regulatory Agency (MHRA), the European Medicines Agency (EMA), and the Society of Obstetricians and Gynaecologists of Canada (SOGC) all released statements saying the same thing: paracetamol remains safe for use during pregnancy, and no credible evidence links it to autism.
This article breaks down the actual science — the studies that exist, what they found, what they did not find, and why every relevant medical authority on the planet rejected the Trump-Kennedy claim. It also examines leucovorin, the treatment Kennedy promoted, and whether it has genuine evidence behind it.
The Claim and Its Political Context
The announcement did not emerge from a scientific discovery. It emerged from a political promise.
In April 2025, Kennedy — who had spent decades promoting debunked theories about vaccines causing autism before being appointed HHS Secretary — told reporters that his department would identify the cause of the rise in autism diagnoses by September. This was an extraordinary promise. Autism spectrum disorder is a complex neurodevelopmental condition with strong genetic underpinnings. Decades of rigorous research have failed to identify a single environmental cause, precisely because autism arises from a constellation of genetic and environmental factors.
When September arrived, the HHS press release used language markedly different from what Trump and Kennedy said at the podium. The official statement acknowledged "contradictory data in the scientific literature and a lack of clear causal connection." It called on clinicians to prescribe acetaminophen at the lowest effective dose for the shortest duration when treatment is necessary — a recommendation that was already standard medical practice before the announcement.
The statement even acknowledged that paracetamol is "often the only available treatment option for pain and fever during pregnancy," since alternatives like nonsteroidal anti-inflammatory drugs (NSAIDs) have well-documented adverse effects on fetal development. In other words, the administration's own written position was substantially weaker than the claim its leaders made on television.
What Paracetamol Is and Why Pregnant Women Take It
Paracetamol (acetaminophen) is the most widely used analgesic and antipyretic in the world. It reduces pain and lowers fever. It has been in clinical use since the 1950s and is available without a prescription in virtually every country. For pregnant women specifically, it occupies a unique position in medicine: it is the only widely recommended over-the-counter pain and fever medication during pregnancy.
This is not because paracetamol is considered perfectly harmless. It is because the alternatives are worse. Ibuprofen and other NSAIDs are associated with premature closure of the ductus arteriosus (a critical fetal blood vessel), reduced amniotic fluid levels, and kidney problems in the fetus, particularly in the third trimester. Aspirin at full analgesic doses carries bleeding risks. Opioids have addiction potential and their own set of fetal complications.
The UpToDate clinical reference, used by physicians worldwide, recommends paracetamol as first-line treatment for pain and fever in pregnancy, with the same caveat that applies to every medication: use the lowest effective dose for the shortest necessary duration. This has been the standard recommendation for decades, across every major obstetric guideline in the world.
Understanding this context is essential. When someone claims paracetamol is dangerous during pregnancy, the follow-up question must always be: compared to what? Untreated high fever during pregnancy is itself associated with adverse outcomes, including neural tube defects and other developmental problems. The risk calculus is not paracetamol versus nothing — it is paracetamol versus the conditions it treats.
The Observational Evidence: What Studies Actually Found
The idea that prenatal acetaminophen exposure might be linked to neurodevelopmental outcomes is not new. It has been investigated in observational studies for over a decade. But understanding what these studies found requires understanding what observational studies can and cannot tell us.
Several large cohort studies have reported statistical associations between maternal acetaminophen use during pregnancy and slightly elevated rates of autism spectrum disorder or attention-deficit/hyperactivity disorder (ADHD) in offspring. A 2016 meta-analysis published in Molecular Psychiatry pooled data from multiple studies and found a modest association between prenatal acetaminophen exposure and hyperactivity or behavioral problems in children.
A 2020 analysis published in Child Psychiatry and Human Development examined the relationship between prenatal acetaminophen use and autism risk, also finding a weak statistical association. And a 2025 systematic review in Environmental Health — published just weeks before the Trump-Kennedy announcement — evaluated six studies and reported some evidence of association.
But here is the critical point that the administration ignored: association is not causation. The lead author of the 2025 review, Didier Prada, told The Washington Post explicitly: "We showed that paracetamol is associated with increased risk, not that it is the cause. These are very different things."
Why Association Does Not Mean Causation
This distinction between association and causation is not a technicality. It is the most important concept in interpreting health research, and misunderstanding it is the single most common way that scientific findings get distorted in public discourse.
When a study finds that women who took paracetamol during pregnancy have children with slightly higher rates of autism, there are multiple possible explanations:
The medication itself could be the cause. This is the explanation the Trump administration promoted. But it is only one possibility among several, and not the one best supported by the evidence.
The condition being treated could be the cause. Women take paracetamol because they have pain, fever, or infections. Maternal infection and inflammation during pregnancy have their own independent associations with neurodevelopmental outcomes. A 2024 review in the European Journal of Pediatrics highlighted this confounding problem: is it the drug, or the illness that prompted the drug use?
Genetic confounding could explain the link. A landmark sibling-control study — where researchers compared siblings born to the same mother, one exposed to prenatal paracetamol and one not — found that the association largely disappeared when genetics were controlled for. This suggests that the same genetic factors that predispose a mother to conditions requiring paracetamol may also predispose her children to neurodevelopmental differences.
Recall bias and measurement error. Most of these studies rely on mothers remembering and reporting their medication use months or years later. Women who have a child diagnosed with autism may be more likely to scrutinize their pregnancy behavior and report any medication use, while women whose children develop typically may not recall or mention occasional paracetamol use.
Publication bias. Studies that find an association are more likely to be published and publicized than studies that find nothing. This systematically inflates the apparent strength of any link in the published literature.
The Sibling Studies: The Strongest Evidence Against a Causal Link
The most powerful method for distinguishing correlation from causation in observational data — short of a randomized controlled trial, which would be unethical in this context — is the sibling-control design.
In a standard cohort study, you compare children whose mothers took paracetamol to children whose mothers did not. But these two groups of mothers may differ in countless ways: health status, stress levels, infection rates, genetics, socioeconomic conditions, diet, healthcare access. Any of these differences could explain the outcomes in their children.
Sibling studies solve much of this problem. When you compare two children born to the same mother — one pregnancy in which she took paracetamol and one in which she did not — you automatically control for genetics, socioeconomic status, household environment, and many other confounders.
A large-scale study published in Paediatric and Perinatal Epidemiology used this approach and found that the association between prenatal paracetamol exposure and autism risk was substantially attenuated — in many analyses, it disappeared entirely — once sibling comparisons were made. This is strong evidence that the observed association in standard studies is driven by confounding factors (primarily genetics and the conditions that prompted medication use) rather than by the drug itself.
This is precisely the kind of evidence that the Trump-Kennedy announcement chose to ignore.
What Every Major Medical Authority Said
The medical response to the September 2025 announcement was not ambiguous. Every relevant professional organization and regulatory agency took the same position: the evidence does not support the claim that paracetamol causes autism.
ACOG (American College of Obstetricians and Gynecologists): Released a statement affirming the safety and benefits of acetaminophen during pregnancy, noting that it remains the recommended first-line treatment for pain and fever in pregnant women and that the evidence does not establish a causal relationship with autism.
SMFM (Society for Maternal-Fetal Medicine): Issued a direct response stating that the administration's claims were not supported by the scientific evidence and warning that discouraging paracetamol use could lead pregnant women to suffer needlessly or turn to more dangerous alternatives.
UK MHRA (Medicines and Healthcare products Regulatory Agency): Published a statement confirming that paracetamol during pregnancy remains safe and that there is no evidence it causes autism in children.
EMA (European Medicines Agency): Stated that its position on paracetamol use during pregnancy remains unchanged in the EU, based on its own review of the available evidence.
SOGC (Society of Obstetricians and Gynaecologists of Canada): Released a position statement reaffirming that acetaminophen is the analgesic of choice during pregnancy and that the evidence does not support a causal link to autism.
This level of unanimous international agreement across regulatory agencies and professional societies is unusual. It reflects how strong the scientific consensus is — and how far outside that consensus the Trump-Kennedy claim fell.
The Real Harm: What Happens When Pregnant Women Avoid Pain Treatment
Political claims about medication safety have real consequences. When an authority figure tells millions of pregnant women that a medication causes autism, some will stop taking it — even when they need it.
This is not a hypothetical concern. After the announcement, obstetricians across the United States reported fielding anxious calls from patients asking whether they should endure severe pain or high fever rather than take acetaminophen. The SMFM response explicitly warned about this danger.
Untreated fever during pregnancy is itself a risk factor for adverse outcomes. Sustained high fever (above 39 degrees Celsius / 102.2 degrees Fahrenheit), especially in the first trimester, has been associated with neural tube defects and other congenital abnormalities. Fever is the body's response to infection, and maternal infection is independently linked to increased risk of neurodevelopmental conditions — including, ironically, autism.
The alternatives to paracetamol are not safer. NSAIDs like ibuprofen carry well-documented fetal risks, particularly after 20 weeks of gestation, including reduced amniotic fluid and premature closure of the ductus arteriosus. The FDA issued a specific warning against NSAID use after 20 weeks of pregnancy in 2020. Aspirin at analgesic doses increases bleeding risk. Opioid analgesics carry their own serious concerns.
The net effect of the Trump-Kennedy announcement was not to protect pregnant women. It was to create fear that could lead them toward worse outcomes — suffering through treatable pain and fever, or switching to medications with genuinely established fetal risks.
Understanding Autism: Genetics, Not a Single Chemical
The premise of the Trump-Kennedy claim — that a single environmental exposure can be identified as "the cause" of autism — reflects a fundamental misunderstanding of what autism spectrum disorder is and how it develops.
Autism is a neurodevelopmental condition with overwhelming evidence of strong genetic contribution. Twin studies consistently show concordance rates of 60-90% for identical twins (who share all their DNA) compared to 0-30% for fraternal twins (who share half). Genome-wide association studies have identified hundreds of genetic variants associated with autism risk, each contributing a small amount. The condition is highly polygenic — it arises from the combined effects of many genes, not from a single gene or a single environmental trigger.
The rise in autism diagnoses that Kennedy frequently cites as evidence of an environmental cause is largely explained by broadened diagnostic criteria (the DSM-5 merged several previously separate diagnoses under the autism spectrum umbrella), increased awareness among parents and clinicians, earlier screening, and reduced stigma leading to more diagnosis-seeking. A JAMA study examining trends in autism diagnosis concluded that changes in diagnostic practices and awareness account for much of the apparent increase.
None of this means environmental factors play zero role. Some environmental factors — such as advanced paternal age, certain prenatal infections, and extreme prematurity — have genuine associations with autism risk. But the framing of autism as a condition caused by a single identifiable chemical, for which a simple cure exists, is scientifically untenable. It reflects an ideological agenda, not a scientific conclusion.
Leucovorin: The Promoted Treatment
Alongside the paracetamol claim, Kennedy promoted leucovorin (calcium folinate, also known as folinic acid) as a treatment for autism. This claim deserves its own examination.
Leucovorin is a form of folic acid that can cross the blood-brain barrier. It has a legitimate medical use: treating cerebral folate transport deficiency, a rare condition in which the transport mechanism that moves folate into the brain is impaired. This condition is real, diagnosed through specific antibody testing and cerebrospinal fluid analysis, and leucovorin is an established treatment for it.
The leap that Kennedy and some researchers have made is from this specific, rare condition to autism broadly. The hypothesis is that some autistic individuals may have subclinical folate transport problems, and that supplementing with leucovorin could improve symptoms — particularly verbal communication.
A small number of studies have tested this hypothesis. A study published in Molecular Psychiatry and work examining folate receptor autoantibodies in autism have reported some positive results, particularly for verbal communication in children with autism who tested positive for folate receptor autoantibodies.
Leucovorin: The Evidence Is Thin
But there are significant problems with the leucovorin evidence that Kennedy did not mention.
First, the studies are small. The most-cited trial involved fewer than 50 participants. Small studies are prone to producing exaggerated effect sizes that shrink or disappear when replicated at larger scale.
Second, most studies lacked a placebo control group. Without a placebo arm, it is impossible to distinguish between the drug's actual effect and the placebo effect — which is substantial in behavioral and communication outcomes, especially when parents know their child is receiving a treatment they believe in.
Third, much of the published research comes from a single group of investigators. When one research team produces most of the evidence for a claim, the risk of systematic methodological biases (conscious or unconscious) is elevated. Independent replication by other groups is essential for confidence, and it has not yet occurred at sufficient scale.
Fourth, even the researchers behind these studies have been careful to say that leucovorin may help a specific subset of autistic individuals — those with documented folate receptor autoantibodies or cerebral folate deficiency — not all autistic people. Kennedy's promotion of it as a broad autism treatment goes beyond what its own proponents claim.
In short, leucovorin is a legitimate medication for a specific rare condition. It may have some benefit for a subset of autistic individuals. But it is not a treatment for autism broadly, and promoting it as such is premature at best and misleading at worst.
The Pattern: How Science Gets Distorted for Political Gain
The paracetamol-autism story follows a pattern that has played out repeatedly in health policy: a political figure makes a bold, simple claim. The claim is based on a selective reading of real but weak evidence. The claim ignores the stronger contradictory evidence. And the claim serves a political narrative — in this case, Kennedy's longstanding crusade against perceived environmental causes of autism, which began with vaccines and has now expanded to include acetaminophen.
The HHS press release itself reveals the tension. The written text was carefully hedged: "contradictory data," "lack of clear causal connection," use the "minimum effective dose for the shortest possible duration." But the public message — delivered by Trump and Kennedy at a press event — was unhedged: paracetamol causes autism.
This gap between the written caveat and the spoken claim is characteristic of politically motivated health messaging. The careful language provides legal cover. The bold statement generates headlines. And the public hears only the headline.
The consequences fall on pregnant women, who now must navigate genuine anxiety about a medication they may need, armed with conflicting information from their government and their doctors.
What Should Pregnant Women Actually Do?
If you are pregnant or planning to become pregnant, here is what the evidence — not the politics — supports:
Paracetamol remains the safest over-the-counter pain and fever medication during pregnancy. This is the position of ACOG, the MHRA, the EMA, the SOGC, and every other relevant medical authority.
Use it when you need it, at the lowest effective dose, for the shortest duration necessary. This has been standard guidance for all medications during pregnancy for decades. It is not new, and it was not prompted by the autism claim.
Do not switch to NSAIDs or other alternatives without medical guidance. Ibuprofen, naproxen, and aspirin carry documented risks to the fetus that are significantly better established than the hypothetical paracetamol-autism link.
Do not endure severe pain or high fever without treatment. Untreated high fever during pregnancy has its own documented associations with adverse fetal outcomes. The goal is not to avoid all medication — it is to use appropriate medication appropriately.
Talk to your doctor if you have concerns. Your obstetrician or midwife can provide personalized guidance based on your medical history, gestational age, and specific symptoms. This is always better than making medication decisions based on political press conferences.
How to Evaluate Health Claims: A Framework
The paracetamol-autism episode offers a case study in how to evaluate health claims critically. Whether the claim comes from a politician, a news headline, or a social media post, these questions can help you assess it:
1. Is there a plausible biological mechanism? For paracetamol, researchers have proposed several mechanisms (oxidative stress, endocrine disruption, interference with neurodevelopment). These are plausible enough to warrant investigation. But plausibility is the lowest bar in science — it means "worth studying," not "proven."
2. What kind of evidence exists? Observational studies showing a weak association are the lowest tier of causal evidence. They generate hypotheses. They do not confirm them. The paracetamol-autism link rests entirely on this tier.
3. Have the findings been replicated? Some studies found an association; others did not. The sibling-control studies — which are methodologically stronger — generally found the association disappeared when genetics were accounted for.
4. What do the experts in the field say? Not a politician, not a general practitioner on social media, not a surgeon commenting outside their specialty — but the people who spend their careers studying this exact question. In this case, they say the evidence does not support a causal claim.
5. What are the consequences of acting on this claim? If the claim is wrong and you stop taking paracetamol during pregnancy, you risk untreated pain and fever with their own documented harms. If the claim is right but you continue taking paracetamol appropriately, the absolute risk increase (if any exists at all) is very small. The risk-benefit calculation strongly favors continued appropriate use.
6. Who is making the claim, and what is their track record? Kennedy's track record on autism causation includes decades of promoting the debunked claim that vaccines cause autism. When someone with a history of false health claims makes a new health claim, the prior probability that the new claim is also wrong is high.
Tracking Medications During Pregnancy
Pregnancy involves dozens of decisions about what medications and supplements to take, when to take them, and at what doses. These decisions are best made in consultation with a healthcare provider, but keeping a clear record of what you take and when can be genuinely useful — both for your own reference and for conversations with your doctor.
WatchMyHealth's medication tracker lets you log every medication, supplement, and vitamin you take, including dose and timing. During pregnancy, this creates a record that you can share with your obstetrician at appointments, ensuring they have accurate information about your medication use.
The app's physician visit tracker can also help you prepare for prenatal appointments — logging questions you want to ask, recording answers, and keeping track of recommendations your provider makes at each visit. When conflicting health information creates anxiety (as the paracetamol-autism news cycle did for many pregnant women), having a direct record of your doctor's specific advice can be grounding.
The Broader Autism Picture: What We Actually Know About Causes
Since the Trump-Kennedy announcement focused narrowly on paracetamol, it is worth stepping back to look at what science has actually established about autism's origins.
Genetics is the dominant factor. Twin and family studies consistently show that autism is one of the most heritable neurodevelopmental conditions. The genetic architecture is complex — hundreds of genes are involved, including both common variants of small effect and rare mutations of larger effect. A comprehensive analysis published in JAMA puts the heritability of autism at approximately 80%, meaning that the vast majority of variation in autism risk is explained by genetic differences.
Some environmental factors have genuine (but modest) associations. Advanced paternal age, extreme prematurity, very low birth weight, certain prenatal infections (particularly rubella and cytomegalovirus), and in-utero exposure to specific medications (most notably valproic acid, an anti-seizure drug) have evidence of association with autism risk. None of these is "the cause" of autism — each contributes a small amount of additional risk on top of the genetic baseline.
The "autism epidemic" is primarily a diagnostic phenomenon. The prevalence of autism diagnoses has increased dramatically since the 1990s, from approximately 1 in 2,500 to current estimates of roughly 1 in 36 children in the United States. But this increase closely tracks broadened diagnostic criteria, increased screening, greater public awareness, and reduced stigma — not a genuine increase in the underlying condition. Studies that have re-evaluated historical populations using current diagnostic criteria find rates comparable to today's.
There is no single cause, and framing autism as having one is misleading. Autism is a spectrum of neurodevelopmental differences arising from complex interactions between many genes and, to a lesser extent, environmental factors. Searching for "the cause" of autism is like searching for "the cause" of height — it fundamentally misunderstands the biology.
Why the "Just Asking Questions" Defense Does Not Apply Here
Some defenders of the Trump-Kennedy announcement have argued that raising questions about medication safety during pregnancy is inherently responsible — that even if the evidence is weak, it is better to be cautious. This argument sounds reasonable but collapses under scrutiny.
First, the administration did not "ask questions." It made declarative claims. Trump said paracetamol causes autism. Kennedy promoted a specific treatment. These are not the cautious postures of scientists exploring a hypothesis.
Second, the "just asking questions" defense ignores the consequences of the answer you imply. When the HHS Secretary tells pregnant women that the only safe pain medication available to them causes autism, some will stop taking it. Some will suffer needlessly. Some will switch to medications with worse safety profiles. The question is not cost-free.
Third, the claim was made against the recommendation of every relevant medical authority. The ACOG statement was not equivocal. The MHRA statement was not ambiguous. The EMA position was unchanged. When every expert body disagrees with you and you proceed anyway, you are not being cautious. You are being reckless.
Genuine scientific caution would have looked very different: conducting additional research, convening an expert panel, publishing the findings in a peer-reviewed journal, and updating guidelines based on the results. Instead, the conclusion was announced at a political press event. That is not how science works.
The Role of Media Literacy in Health Decisions
The paracetamol-autism story spread rapidly across social media, news outlets, and messaging groups. Within hours, pregnant women around the world were seeing alarming headlines. How do you navigate this kind of information environment?
Check who is reporting it and what sources they cite. The Washington Post coverage included quotes from the lead researcher of the cited review explicitly saying the evidence does not show causation. Many social media posts included only the Trump-Kennedy claim without this crucial context.
Look for the response from professional organizations. Within 48 hours, ACOG, SMFM, MHRA, EMA, and SOGC had all issued responses. When every medical authority in the field pushes back against a government claim, that is an extraordinarily strong signal.
Distinguish between the written statement and the spoken claim. The HHS press release was much more cautious than what was said at the podium. Always read the actual document, not just the headline about it.
Be wary of simple explanations for complex conditions. Autism has been the target of simplistic causal theories for decades — vaccines, mercury, gluten, screen time, and now paracetamol. The pattern is always the same: a confident claim, widespread fear, and eventual debunking. The underlying reality — that autism is a complex genetic condition without a single environmental cause — is less dramatic but more accurate.
What Good Research on This Topic Would Look Like
If the Trump administration genuinely wanted to investigate the paracetamol-autism question responsibly, there is a well-established framework for doing so. It has not been followed.
The gold standard would be a large-scale, prospective cohort study with several key features: enrollment before pregnancy or in early pregnancy (to avoid recall bias in medication reporting), careful documentation of paracetamol use including dose and duration, comprehensive tracking of the conditions that prompted use (to separate drug effects from disease effects), long-term follow-up of children through the age when autism can be reliably diagnosed, and statistical methods that account for genetic confounding (ideally sibling-control or other family-based designs).
Such a study would take years and cost tens of millions of dollars. It would need to be large enough — likely tens of thousands of participants — to detect small effects with confidence. And it would need to be conducted by independent researchers, not by a political appointee with a decades-long commitment to a specific conclusion.
What the administration did instead was cite existing observational studies that their own written statement acknowledged were contradictory, declare a conclusion those studies do not support, and announce it at a press conference. This is politics. It is not science.
A Note on Autism Itself
Any discussion of purported autism "causes" and "treatments" should acknowledge something the Trump-Kennedy framing entirely ignored: autism is not a disease to be cured. It is a neurodevelopmental condition that encompasses an enormous range of abilities, challenges, and experiences.
Many autistic adults find the constant search for a "cause" to be dehumanizing — as though their existence is a problem to be solved rather than a difference to be understood and accommodated. The framing of autism as an epidemic caused by environmental toxins, rather than a natural variation in human neurology that has always existed, causes real harm to autistic people and their families.
This does not mean that research into autism's biological basis is unwelcome. Many autistic individuals and families want better understanding, better support, and better interventions for specific challenges (such as communication difficulties or sensory sensitivities). But research conducted in good faith, guided by scientific evidence, is very different from political campaigns that use autism as a rhetorical tool.
The autistic community has been vocal about this distinction. Their voices deserve to be heard alongside the scientific evidence when evaluating claims about their condition.
Practical Takeaways
Let us close with clear, evidence-based takeaways:
1. Paracetamol (acetaminophen) remains the recommended pain and fever medication during pregnancy. This is the consensus of ACOG, MHRA, EMA, SOGC, and every relevant medical authority worldwide.
2. The evidence does not support a causal link between paracetamol and autism. Some observational studies found weak associations. Stronger study designs (sibling controls) found these associations disappeared when genetics were accounted for. No medical authority considers the evidence sufficient to change treatment guidelines.
3. Use the lowest effective dose for the shortest necessary duration. This is standard advice for all medications during pregnancy and has been for decades. It was not prompted by the autism claim.
4. Do not switch to NSAIDs or skip treatment without medical guidance. The alternatives to paracetamol carry better-established fetal risks. Untreated fever carries its own risks.
5. Leucovorin is not a proven treatment for autism broadly. It has a legitimate role in treating the rare condition of cerebral folate transport deficiency and may benefit a small subset of autistic individuals, but the evidence is preliminary and limited.
6. Autism is primarily genetic. It is not caused by a single environmental exposure, and searching for one reflects misunderstanding of the condition's biology.
7. Follow your doctor's advice, not political press conferences. Your obstetrician has access to the same evidence the regulatory agencies reviewed and can provide personalized guidance for your specific situation.
Using Health Tracking to Stay Informed and In Control
Navigating pregnancy health decisions in an era of conflicting information is stressful. One practical way to reduce anxiety is to maintain clear, organized records of your health data and medical interactions.
WatchMyHealth's medication tracker helps you log every medication and supplement, creating a comprehensive record you can review with your healthcare provider. The physician visit tracker lets you document questions, advice, and follow-up plans from each prenatal appointment. And the app's wellbeing tracker can help you monitor how you are feeling day to day — capturing patterns in mood, energy, and stress that are useful to share with your care team.
When headlines create confusion about what is safe, having a direct, documented relationship with your healthcare provider — supported by accurate records of your health data — is the most reliable foundation for good decisions.
